The addition of erlotinib to gemcitabine and cisplatin does...

Investigational New Drugs 2013 / 10 Vol. 31; Iss. 5

The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer

Khalil, Mohamed A., Qiao, Wei, Carlson, Peter, George, Binsah, Javle, Milind, Overman, Michael, Varadhachary, Gauri, Wolff, Robert A., Abbruzzese, James L., Fogelman, David R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-013-9967-2
Date:
October, 2013
File:
PDF, 246 KB
english, 2013
Conversion to is in progress
Conversion to is failed